Chin Filler: A UK Practitioner's Guide
Read Blog
This article is intended for qualified aesthetic practitioners (doctors, dentists, nurses and other appropriately trained prescribers and injectors). It is not patient advice.
Cheek filler is one of the most requested treatments in UK clinics, and one of the easiest to get subtly wrong. A well-placed midface treatment can support the lower eyelid, soften the nasolabial area and improve how the whole face carries light. Poorly planned, it produces the overfilled, rounded "pillow face" that patients increasingly want to avoid. This guide covers the anatomy, product selection, needle versus cannula decisions, marking, volumes and risk management that matter most when you plan cheek treatments.
Many patients ask for "cheekbones", but the more useful clinical question is what the midface has lost and where. Volume change in the cheek is rarely uniform. It involves deflation and descent of distinct fat compartments, bony remodelling of the maxilla and orbital rim, and changing support from the retaining ligaments.
The classic description of these compartments comes from Rohrich and Pessa's cadaver work, The Fat Compartments of the Face (Plastic and Reconstructive Surgery, 2007). It showed that facial fat is partitioned into separate superficial and deep compartments rather than forming one confluent layer. In practice, that means restoring a deep medial cheek compartment behaves very differently from adding product superficially over the zygoma.
Before choosing a product, decide what the face needs. A useful way to frame it is to separate three goals that patients often lump together.
Lateral support along the zygomatic arch gives width and a subtle lifting vector, and often improves the lower face indirectly. Anterior projection over the medial cheek restores fullness lost with age and softens the tear trough-cheek transition. Contour definition, the sculpted "high cheekbone" look, uses small boluses at the apex and is the area most prone to overcorrection.
Assess the patient at rest, smiling and from oblique and profile views. Look at skin thickness, the presence of malar oedema or festoons, how prominent the zygoma already is, and whether lower-eyelid hollowing would be better addressed by restoring the cheek first. Photograph from standardised angles and record your findings. This feeds directly into consent and your clinical notes.
There is no single best filler for cheeks. The right product depends on depth, the amount of lift needed, skin thickness and your technique. In general, midface work calls for gels with higher elasticity (G′) and cohesivity that hold shape under pressure, particularly for supraperiosteal placement. Softer, more flexible gels suit superficial blending or thin-skinned areas near the lid-cheek junction.
Products commonly selected for the midface include:
Always check each product's instructions for use for its indicated depth, area and maximum volumes, and use what you have been trained on. You can compare options across brands in our cheek volume filler collection.
Marking is where planning becomes technique. With the patient upright, many practitioners start by drawing a line from the lateral canthus to the oral commissure and a second from the tragus (or the inferior border of the nasal ala) towards the lateral canthus. The intersections help divide the midface into zones and keep apical injections lateral and above the line where projection looks natural.
Common cheek filler injection points include:
Mark the infraorbital foramen and stay well clear of the orbital rim with deep needle boluses. Note any asymmetry before treatment. Most faces have some, and patients will notice it afterwards if you have not pointed it out first.
Both have a place, and many experienced injectors combine them.
A needle (often 27G or 25G, depending on the product) allows precise supraperiosteal boluses on the zygoma, where accuracy of depth matters and the bone gives a firm end point. Aspiration before injecting is widely practised, although it is not a reliable safety test on its own, and slow, low-pressure injection of small aliquots remains essential.
A blunt cannula (commonly 22G or 25G) is useful for the anteromedial and submalar cheek. It allows fanning across a wider area from a single entry point, often with less bruising. A cannula lowers the risk of intravascular injection but does not remove it, particularly with finer gauges. If you are choosing between gauges and lengths, our cannula buying guide covers the trade-offs in detail, and you can browse the full cannula range.
Patients often arrive asking for a fixed amount, typically 1ml or 2ml. Volume should follow the assessment, not the other way round. A young patient seeking subtle lateral definition may need well under 1ml in total. An older patient with marked midface deflation may need more, ideally spread across staged appointments.
Staging has real advantages. It lets tissue settle, gives you a chance to reassess integration and swelling, and reduces the risk of overcorrection. Many practitioners build cheek volume over two sessions a few weeks apart rather than placing a large volume at once. Whatever you plan, record the product, batch number, volume and site for each injection.
Lateral midface support can improve the appearance of the lower face and jawline in some patients by changing the lifting vector, but it will not correct significant jowling or skin laxity on its own. Be clear about this during consultation. Where laxity is the main issue, combined approaches or referral may be more appropriate than adding volume.
The midface carries a real risk of vascular compromise, especially near the infraorbital and angular arteries and in the medial cheek close to the nasolabial region. Other complications include bruising, oedema, nodules, delayed-onset inflammatory reactions, malar oedema and filler migration.
Practical safeguards include:
Your consent conversation should cover these risks in plain language, as well as the expected longevity, the possibility of needing further sessions, and the option of dissolving the product. Document it fully. Our guide to aesthetic insurance explains why your notes and protocols matter if a claim ever arises.
Give written aftercare advice: avoid pressing or massaging the area unless instructed, avoid strenuous exercise, saunas and heavy facial pressure for the period your protocol specifies, and contact the clinic immediately if pain, skin colour changes or visual disturbance develop. Book a review, commonly at around two weeks, to assess symmetry and integration once initial swelling has settled.
Longevity varies with the product, the depth of placement, the treated area and individual metabolism. Manufacturers' data for midface HA fillers typically describe results lasting from several months to more than a year, so check the specific product's instructions for use and set expectations on that basis rather than quoting a single figure.
The main concerns are overcorrection and an unnatural result, swelling and bruising, malar oedema, nodules, migration and, most seriously, vascular occlusion. Careful assessment, conservative volumes, staged treatment and complication readiness reduce these risks but cannot eliminate them.
There is no universal "never" map, but practitioners take particular care around the infraorbital foramen, the medial cheek near the course of the angular artery, and the area directly beneath the orbital rim. Patients with existing malar bags or festoons are often poor candidates for filler in the upper cheek, as it can make swelling worse.
A blunt cannula is generally considered to lower the risk of intravascular injection and bruising, particularly in the medial and submalar cheek. It does not remove the risk. Many practitioners still use a needle for precise supraperiosteal boluses on the zygoma and a cannula for broader deep or subcutaneous work.
It depends on the assessment. Some patients need less than 1ml for subtle definition, while others with marked deflation need more, ideally spread over staged sessions. Base the plan on facial analysis and the product's IFU rather than a fixed syringe count.
Good cheek filler work starts with anatomy and assessment, not with the syringe. Decide whether the face needs lateral support, anterior projection or contour, choose a product with the right rheology for the depth, mark carefully and stay conservative. Combine that with solid consent, clear documentation and a tested complication protocol, and you can deliver midface results that look natural and age well. When you are ready to stock up, explore our cheek volume fillers and cannulas.